- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 22.58M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $330.8M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $332.63M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $328.48M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $292.81M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $107.49M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $99.67M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $739.48M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $669.03M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $897.16M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $810.43M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.39B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.3B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 22.95M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $8.42M |
| Capex | Q1 2025 · Mar 31, 2024 | $30.16M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $41.55M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.21B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.22B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.61 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.61 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $22.69M |
| Net Income | Q1 2025 · Mar 31, 2024 | $13.89M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $20.17M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $70.28M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $481.14M |
| Revenue | Q1 2025 · Mar 31, 2024 | $551.42M |